Thrombopoietin (Tpo), the ligand for the ompl receptor, is a major regulator of platelet production in vivo. Treatment of mice with purified recombinant Tpo increases platelet count fourfold and expands colony-forming unit-megakaryocyte (CFU-Meg) numbers. Other cytokines including interleukin-3 (IL-3). IL-6, IL-11, erythropoietin (Epo), and stem cell factor (SCF) can stimulate megakaryopoiesis. Therefore, we examined the effects of recombinant murine Tpo in combination with these cytokines on megakaryopoiesis in vitro. Murine marrow cells were cultured in agar in Iscove's modified Dulbecco's medium (IMDM) supplemented with 1096 horse serum and P-mercaptoethanol in the presence of recombinant growth factors, and CFU-Meg colonies were counted on day 5. Megakaryocyte ploidy was analyzed using murine marrow cells cultured for 5 days in IMDM supplemented with 1% nutridoma-SP and recombinant growth factors. Megakaryocytes were identified by labeling with the 4A5 antibody and ploidy was analyzed by flow cytometry. Tpo supported the growth of CFU-Meg in a dose-dependent LATELETS, the "blood dust,"' are produced by fragmentation of megakaryocyte cytoplasm. The committed hematopoietic progenitor cells, colony-forming unitsmegakaryocyte (CFU-Meg), that differentiate into megakaryocytes undergo a variable number of mitotic divisions, then cease to proliferate and undergo 3 to 5 synchronized nuclear endomitoses, giving rise to polyploid megakaryocytes. The cell volume of megakaryocytes approximately doubles with each nuclear endoreduplication.' Both the number and size of megakaryocytes determine the quantity of cytoplasm available for platelet production. Thus the balance between the mitotic and endomitotic pathways of megakaryocytes development influences the number of platelets produced per megakaryocytic progenitor cek3
Megakaryopoiesis is governed by a number of hematopoietic growth factor^.^.^ Interleukin-3 (IL-3) is a potent stimulant of CFU-Meg proliferation, but has little effect on megakaryocyte maturation.' IL-6, IL-11, stem cell factor (SCF), and leukemia inhibitory factor display scant to no megakaryocyte colony-stimulating activity as single agents in vitro, but can augment the effects of IL-3 on megakaryocyte colony growth."" The predominant effects of IL-6 and IL-11 are on megakaryocyte maturati~n.~.~.'' Epo modestly enhances both CFU-Meg proliferation and megakaryocyte maturation,' [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Thrombopoietin (Tpo), the ligand for the c-mpl receptor, has recently been purified from the serum of thrombocytopenic and cDNA clones encoding murine Tpo have been obtained by several g r o~p s . '~, '~,~~ Treatment of mice with Tpo causes a fourfold increase in platelet count within 5 days, increases the number of megakaryocytes in the marrow, and expands the number of megakaryocyte progenitor cells 20- manner. Although the addition of SCF (50 ng/mL), Epo (2 U/mL), or IL-l1 (50 ng/mL) alone exerted only a modest effect on CFU-Meg growth, the combinations of SCF plus Tpo, Epo plus Tpo, or IL-l1 plus Tpo resulted in a synergistic enhancement of the number of CFU-Meg colonies. IL-3 alone supported CFU-Meg colony growth, and the effects of IL-3 plus Tpo or IL-6 plus Tpo on colony growth appeared to be approximately additive. Fifhl percent of megakaryocytes generated in cultures containing IL-3 or Epo displayed s16N ploidy. In contrast, cultures containing Tpo uniquely generated large numbers (30% to 359' 0 of the total) of megakaryocytes with z64N ploidy. These results show that Tpo stimulates both proliferation of committed megakaryocytic progenitor cells and maturation of megakaryocytes, and that two multipotent cytokines, SCF and IL-11. as well as a lateacting erythroid cytokine, Epo, can synergize with Tpo to stimulate proliferation of CFU-Meg. progenitor cells resulted in the generation of megakaryocytes in suspension culture." Flow cytometric analysis with an anti-c-mpl receptor monoclonal antibody (MoAb) showed that -50% of AA4' Sca+ primitive murine hematopoietic cells coexpress the c-mpl receptor." The use of c-mpl antisense oligonucleotides in hematopoietic colony-forming assays in vitro specifically inhibits the growth of human CFU-Meg, but not burst forming units-erythroid (BFU-E) or CFU granulocyte-macrophage (CFU-GM), suggesting that signal transduction via the c-mpl receptor is important for proliferation of megakaryocyte progenitor cells." Mice engineered to lack expression of the c-mpl receptor by homologous recombination in embryonic stem cells exhibit an 85% reduction in platelet count, and a decrease in the number of megakaryocytes in the although megakaryopoiesis is not completely ablated. These data suggest that Tpo plays a key role in the regulation of thrombopoiesis in vivo.
For these reasons, we decided to evaluate the effects of Tpo on the proliferation and differentiation of murine megakaryocyte progenitor cells in vitro. The present model of regulation of platelet prod~ction'~.*~ predicts that Tpo would be a late-acting factor that primarily regulates terminal maturation of megakaryocytes (endoreduplication and cytoplasmic maturation). However, our results show that Tpo also stimulates proliferation of CFU-Meg as effectively as IL-3, and that Epo, SCF, and IL-11, three cytokines that display minimal megakaryocyte colony-stimulating activity alone, synergiLe with Tpo to promote CFU-Meg growth.
These data suggest that Tpo acts on both the mitotic and endomitotic pathways of megakaryopoiesis, in contrast with IL-3, which is primarily a proliferation factor. ' x Fifty units of activity was defined as the quantity of Tpo that gace one-half maximal stimulation in the Bat.S/mpl poliferation a s~a y . '~ Recombinant human erythropoietin (Epo), recombinant murine IL-3, and recombinant murine GM colony-st~mulating factor were expressed in BHK cells as previously described." '') Puntied recombinant murine stem cell factor was a glft from Amgen, Inc (Thousand Oaks, CA). Purified recombinant human L 6 and IL-I I were obtained from Gen- 30 &mL DNAse-free RNAse (Boehringer Mannheim) and 0.1% Triton X-100, and analyzed in a Coulter Epics Elite flow cytometer with an argon ion laser (emission 488 nm). A 70-pm prefilter was used. An electronic gate was set on the green fluorescence channel that excluded 99% of the cells labeled with the control MoAb. The DNA content of the cells labeled with the 4A5 antibody was analyzed by setting markers at the nadirs between the propidium iodide peaks. The 2N and 4N peak positions were identical to those of ungated cells. Approximately 2,000 to 10,000 megakaryocytes from each individual liquid culture were analyzed. Geometric mean ploidy was calculated as described.3J
MATERIALS AND METHODS

Megakatyocyte
RESULTS
Megakaryocytic colony growth.
We examined the ability of recombinant murine Tpo alone or in combination with other cytokines to support the growth of megakaryocytic colonies in serum-containing semisolid media. Tpo exerted a concentration-dependent effect on CFU-Meg proliferation that was maximal at -2,000 U/mL of Tpo (Fig l) . Although Epo (2 U/mL) alone did not support CFU-Meg growth (0.3 t-0.3, 0.7 -+ 0.7, I -+ 0, 2 -+ 0.6 and 5 -+ 0.6 colonies/2 X 10' cells in five separate experiments), the combination of Epo plus Tpo dramatically increased CFU-Meg colony numbers a t all concentrations of Tpo tested (Fig 2 and Table 1) . Likewise, the use of SCF alone resulted in only a modest effect on CFU-Meg colony growth (0, 0.5, 2.7 -+ 1.4, and 5.7 -+ 0.7 colonies/2 X 10' cells plated in four separate experiments). However, the combination of SCF plus Tpo also markedly increased the number of CFU-Meg colonies in a supraadditive fashion (Fig 2 and (Fig 2 and Table  I ). Although IL-l1 displayed little megakaryocyte colonystimulating activity, the addition of IL-11 to low concentrations of Tpo ( 1 5 to 75 U/mL) increased the number of CFUMeg colonies by at least twofold, in comparison with the number found in the presence of Tpo alone (Fig 3) . IL-6. a cytokine that predominately affects megakaryocyte maturation, had an approximately additive effect on CFU-Meg growth in the presence of low concentrations of Tpo (Fig  3) . At higher concentrations of Tpo, the presence of IL-6 did not augment the growth of CFU-Meg colonies (Fig 3) . In two experiments, the addition of GM-CSF ( 10 ng/mL) to various concentrations of Tpo (15 to 2,000 U/mL) had no effect on CFU-Meg colony growth (data not shown).
The number of cells in each CFU-Meg colony reflects the activity of the mitotic pathway of megakaryopoiesis. Growth factors that act primarily on proliferation of megakaryocyte progenitor cells would be expected to generate colonies containing large numbers of megakaryocytes. The CFU-Meg
For colonies grown in the presence of IL-3 contained more megakaryocytes per colony, on average, than those grown in Tpo, Epo, or SCF ( Table l ) . IL-3 uniquely generated a few very large colonies containing more than 50 megakaryocytes (Table l). Although the combination of Tpo plus IL-3 displayed an additive effect on the number of CFU-Meg colonies, there was an increase in the proportion of larger colonies, so that overall many more megakaryocytes were produced than in the presence of either cytokine alone. The few CFU-Meg colonies identified in the presence of Epo or SCF alone were small (Table l) . However, in addition to augmenting the number of CFU-Meg colonies, the combination of Tpo plus Epo or Tpo plus SCF also increased the size of the colonies, resulting in at least 50% of the colonies containing 6 to 19 megakaryocytes. In the presence of 2,000 U/mL of Tpo, the addition of IL-6 did not change the size distribution of the megakaryocyte colonies. Table 2) . When the marrow cells were cultured in Tpo and IL-3 was added on day 3, both the number and the size of the CFU-Meg colonies were approximately the same as those generated in the presence of Tpo alone, suggesting that IL-3 does not stimulate the proliferation of the more mature megakaryocytic cells present after 3 days in culture. However, when the cells were cultured in the presence of IL-3 and Tpo was added on day 3, the number of CFU-Meg colonies was increased over that seen in the presence of IL-3 alone, indicating that Tpo can enhance the proliferation of more mature cells in the megakaryocytic lineage. Analysis of megakaryocyte polyploidy. We cultured murine marrow cells in serum-free liquid cultures6 in the presence of hematopoietic growth factors to analyze the effects of Tpo on megakaryocyte endoreduplication. In the presence of Tpo (2,000 U/mL), large smooth cells developed by day 3 to 5 of culture (Fig 4) . Cytoplasmic blebbing was observed in some of these cells. Acetylcholinesterase staining verified that the large cells are megakaryocytes. In accord with the -. Murine marrow cells were cultured at a concentration of 2 x lo5 cells/mL in 0.275% agar in IMDM supplemented with 10% horse serum, 5
x mol/L p-mercaptoethanol, and combinations of cytokines. The number of colonies containing 3 to 5,6 to 19, 20 to 50, or more than 50 individual megakaryocytes was counted on day 5 using an inverted microscope. The data represent the mean t SEM of triplicate plates. Two additional experiments gave similar results.
Average of duplicate plates.
effects of IL-3 on CFU-Meg colony growth, and prior rep o r t~,~ IL-3 (20 ng/mL) also supported generation of large numbers of megakaryocytes in serum-free liquid cultures (data not shown). For analysis of megakaryocyte ploidy, the cells generated in liquid culture were labeled with purified 4A5 MoAb (or with rat IgG2a control antibody) and incubated with propidium iodide. Flow cytometric analysis showed that in cultures containing Tpo, cells of greater than 4N ploidy were frequent enough to be identified on a DNA 3 601
histogram that included all of the cells (data not shown). The DNA content of the cells that were most intensely stained with the 4A5 antibody was analyzed as described.'* As the concentration of Tpo increased, megakaryocyte ploidy increased ( Table 3) . Geometric mean p l~i d y '~ was maximal at a Tpo concentration of 500 U/mL (two independent experiments). In the presence of Tpo (2 150 U/mL, the modal megakaryocyte ploidy number was 64N, and 5% to 7% of the megakaryocytes had a ploidy of 128N ( Table 3 For Murine marrow cells were cultured as described in Table 1 , and CFU-Meg colonies were counted on day 5. Where indicated, the addition of IL-3 or Tpo was delayed until day 3 of culture. The data represent the mean t SEM of triplicate or quadruplicate plates from one experiment. A second experiment with delayed addition of Tpo or IL-3 gave similar results. Fig 5) . In contrast, more than 50% of the megakaryocytes in L-3-containing cultures exhibited 5 8 N ploidy, and relatively few displayed 264N ploidy (Fig 6) . These data indicate that, although L -3 is a potent stimulant of CFU-Meg proliferation, it is much less active than Tpo at promoting megakaryocyte endomitosis. No megakaryocytes of ~6 4 N ploidy were identified in liquid cultures that contained Epo alone (Fig 6) . In the presence of Epo plus a high concentration of Tpo (2,000 U/mL), the distribution of megakaryocyte DNA content was very similar to that of cells cultured in Tpo alone ( Table 3) , showing that at the concentration tested, Epo did not augment the megakaryocyte endoduplication induced by Tpo.
DISCUSSION
The induction of acute thrombocytopenia by exchange transfusion or by treatment with antiplatelet antibodies re- sults in a reproducible sequence of events. Megakaryocyte size3' and p l~i d y~' ,~~ increase by 48 to 72 hours. In contrast to these effects on megakaryocyte maturation, modest to no changes in the number of marrow megakaryocyte precursor and progenitor cells are found 4 to 5 days after the development of thromb~cytopenia.~' Conversely, hypertransfusion of platelets reduces megakaryocyte ploidy in normal rats3' These findings have led to the concept of two distinct levels of regulation of thrombopoiesis in vivo: a megakaryocyte proliferation factor that stimulates CFU-Meg growth, and a megakaryocyte potentiation factor that stimulates megakaryocyte endoreduplication." In this model of the regulation of thrombopoiesis, megakaryocyte proliferation factor is proposed to be constitutively present, whereas megakaryocyte potentiation factor is exquisitely regulated by the platelet count.
IL-3, which is constitutively produced by T cells present in the marrow microenvironment, is a candidate for the megakaryocyte proliferation factor, but the cytokine that predominantly affects megakaryocyte maturation had remained elusive. Both IL-6 and IL-l1 enhance megakaryocyte endoreduplication in vitro, but are pleiotrophic cytokines whose levels do not fluctuate inversely with the platelet ~o u n t .~~. "
However, Tpo levels increase within 8 hours after thrombocytopenia developslh~20 and platelet transfusions within this period abolish the increase in Tpo. The present results show that Tpo has a profound effect on megakaryocyte endoreduplication, generating a large proportion of megakaryocytes with a ploidy of 32 to 128N, reinforcing the identification of Tpo as megakaryocyte potentiation fact~r . '~. '~ Using morphological criteria, Levine et a12 have suggested that the majority of 4N to 8N megakaryocytes are immature and that 95% of megakaryocytes that are capable of producing platelets are at least 16N to 32N. Thus the ability of Tpo to enhance megakaryocyte polyploidization may have a significant impact on total platelet production capacity.
Contrary to the prediction of the model of thrombopoiesis, the effects of Tpo are not limited to promotion of megakaryocyte maturation; Tpo is also a potent stimulant of CFU-Meg proliferation.14.18320 Experiments with enriched populations of hematopoietic stem cells and progenitor cells indicate that the proliferative effects of Tpo are not mediated by accessory cells." Our data document the effects of Tpo on proliferation of the more differentiated megakaryocyte progenitor cell, CFU-Meg. Whether more primitive megakaryocytic progen- itor cells (BFU-Meg, high proliferative potential [HPPI-CFU-Meg)." will respond to Tpo requires further investigation. Although full maturation and platelet production is not achieved in vitro in the absence of Tpo?" inhibition of the biologic effects of Tpo using a soluble form of the c-mpl receptor suggests that a subset of CFU-Meg proliferate in vitro in response to IL-3 alone. The present results show that optimal levels of IL-3 or Tpo can stimulate the growth of similar numbers of CFU-Meg, and that these growth factors exert an additive effect on megakaryopoiesis in vitro. Thus there may be two populations of CFU-Meg progenitor cells: one that is responsive to IL-3 and maintains steady state thrombopoiesis, and one that is responsive to Tpo and may contribute to megakaryocyte expansion in response to acute thrombocytopenia. These data lead us to propose a modified model of regulation of thrombopoiesis. In this model, IL-3 maintains steadystate proliferation of CFU-Meg. Tpo present in the serum at a low concentration, IL-6, and IL-l I modestly augment the proliferative effects of IL-3, and predominantly induce megakaryocyte maturation. In response to acute thrombocytopenia, serum levels of Tpo increase abruptly, resulting in a prompt increase in megakaryocyte size and polyploidy, and an increase in platelet production per megakaryocyte. At high concentrations, Tpo is also a potent stimulant of CFUMeg proliferation and recruits additional megakaryocyte progenitor cells to proliferate. S C P ' and Epo circulate at measurable levels in the blood under normal circumstances, and synergistically enhance the effect of moderate to high concentrations of Tpo on CFU-Meg proliferation. However, elevated levels or the administration of SCF or Epo fail to raise the platelet counts above normal because of the Tpo dependence of platelet production mediated by SCF or Epo.
Mice that do not express the c-mpl receptor have peripheral platelet counts that are 15% of normal, and normal red blood cell and white blood cell numbers.2' These results support the concept that Tpo plays a major role in the control of thrombopoiesis in vivo. However, some platelets are produced even in the absence of c-mpl activity, suggesting that Tpo may not be absolutely essential for terminal megakaryocyte maturation in vivo. Determining whether the number 
